2026 Pascal Chanez: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	98	774	708	24	23	463	48564
Medicine	99	8444	7935	258	244	472	48676

Overview

Pascal Chanez is affiliated with Aix-Marseille University in France. The research focus is primarily within the field of Medicine, with a substantial body of work in Pulmonary and Respiratory Medicine, Physiology, Immunology and Allergy, Immunology, and Surgery.

The scientist's research centers on topics including:

Asthma and respiratory diseases
Respiratory and Cough-Related Research
Allergic Rhinitis and Sensitization
Chronic Obstructive Pulmonary Disease (COPD) Research
IL-33, ST2, and ILC Pathways
Neonatal Respiratory Health Research
Inhalation and Respiratory Drug Delivery

Frequent coauthors collaborating with Pascal Chanez include Arnaud Bourdin, Delphine Gras, Ian M. Adcock, Peter Howarth, and Ratko Djukanović.

Major publication venues where this researcher has contributed extensively include:

Revue des Maladies Respiratoires
Revue française d'allergologie
Revue des Maladies Respiratoires Actualités
European Respiratory Review
European Respiratory Journal

Notable recent papers authored or coauthored by Pascal Chanez encompass the following works:

Eosinophils in Health and Disease: A State-of-the-Art Review, 2021, Mayo Clinic Proceedings
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial, 2020, The Lancet Respiratory Medicine
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study, 2020, The Lancet Respiratory Medicine
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study, 2023, The Lancet Respiratory Medicine
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme, 2020, European Respiratory Journal

Best Publications

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush

4568
Citations
Eosinophilic inflammation in asthma.

J Bousquet;P Chanez;J Y Lacoste;G Barnéon

3269
Citations
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker

2515
Citations
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle

2481
Citations
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet

1802
Citations
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R Bleecker;J Mark FitzGerald;Pascal Chanez;Alberto Papi

1595
Citations
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

B Abraham;JM Anto;E Barreiro;Ehd Bel

1047
Citations
Induction of nitric oxide synthase in asthma

Q Hamid;Springall;JM Polak;V Riveros-Moreno

1043
Citations
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

Helgo Magnussen;Bernd Disse;Roberto Rodriguez-Roisin;Anne Kirsten

809
Citations
Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis

A M Vignola;P Chanez;G Chiappara;A Merendino

773
Citations
A new perspective on concepts of asthma severity and control

D. R. Taylor;E. D. Bateman;L.-P. Boulet;H. A. Boushey

689
Citations
Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells

Martijn J. Schuijs;Monique A. Willart;Karl Vergote;Delphine Gras

639
Citations
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

Dominick E. Shaw;Ana R. Sousa;Stephen J. Fowler;Louise J. Fleming

613
Citations
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.

Ian D. Pavord;Pascal Chanez;Gerard J. Criner;Huib A.M. Kerstjens

600
Citations
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

Fernando Holguin;Juan Carlos Cardet;Kian Fan Chung;Sarah Diver

597
Citations
Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic Bronchitis

Antonio M. Vignola;Loredana Riccobono;Angela Mirabella;Mirella Profita

571
Citations
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.

Sally E. Wenzel;Peter J. Barnes;Eugene R. Bleecker;Jean Bousquet

567
Citations
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease.

Jean-Yves Lacoste;Jean Bousquet;Pascal Chanez;Thierry Van Vyve

559
Citations
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society

KF Chung;P Godard;E Adelroth;J Ayres

532
Citations
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

Henrik Watz;Kay Tetzlaff;Kay Tetzlaff;Emiel F M Wouters;Anne Kirsten

511
Citations

Frequent Co-Authors

Jean Bousquet University of Montpellier

Nicolas Roche Université Paris Cité

Peter J. Sterk University of Amsterdam

Ratko Djukanovic University of Southampton

Kian Fan Chung Imperial College London

Norbert Krug Fraunhofer Society

Thomas Sandström Umeå University

Peter H. Howarth University of Southampton

Ian M. Adcock Imperial College London

Sven-Erik Dahlén Karolinska Institute

External Links

Personal website of Pascal Chanez

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your education into nursing and healthcare management can open diverse career paths. Many professionals pursue advanced nursing degrees online to specialize further and improve their job prospects.

One popular route is enrolling in online nursing programs for non nurses, which offer accelerated pathways for individuals without a traditional nursing background. These programs lay the foundation for becoming a licensed nurse and advancing in healthcare roles.

After gaining nursing credentials, some aim for specialized fields like acute care. Transitioning through acute care nurse practitioner programs allows nurses to manage complex patient conditions in hospital settings, a highly in-demand specialization.

Many students opt for a faster route by choosing nurse practitioner accelerated program options, cutting down time spent in school while still meeting certification criteria.

Salary expectations vary by location, but those with advanced nursing degrees generally see promising earnings. For example, the dnp salary by state resource offers a clear overview of potential income across the USA, helping candidates plan their career growth strategically.